<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Phytother Res</journal-id><journal-id journal-id-type="iso-abbrev">Phytother Res</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1099-1573</journal-id><journal-id journal-id-type="publisher-id">PTR</journal-id><journal-title-group><journal-title>Phytotherapy Research</journal-title></journal-title-group><issn pub-type="ppub">0951-418X</issn><issn pub-type="epub">1099-1573</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Ltd.</publisher-name><publisher-loc>Chichester, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7436756</article-id><article-id pub-id-type="doi">10.1002/ptr.6802</article-id><article-id pub-id-type="publisher-id">PTR6802</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>Evaluation of medicinal herbs as a potential therapeutic option against <styled-content style="fixed-case" toggle="no">SARS&#x02010;CoV</styled-content>&#x02010;2 targeting its main protease</article-title><alt-title alt-title-type="left-running-head">Upadhyay et al.</alt-title></title-group><contrib-group><contrib id="ptr6802-cr-0001" contrib-type="author"><name><surname>Upadhyay</surname><given-names>Saurabh</given-names></name><xref ref-type="aff" rid="ptr6802-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ptr6802-cr-0002" contrib-type="author"><name><surname>Tripathi</surname><given-names>Praveen K.</given-names></name><xref ref-type="aff" rid="ptr6802-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ptr6802-cr-0003" contrib-type="author"><name><surname>Singh</surname><given-names>Manju</given-names></name><xref ref-type="aff" rid="ptr6802-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="ptr6802-cr-0004" contrib-type="author"><name><surname>Raghavendhar</surname><given-names>Siva</given-names></name><xref ref-type="aff" rid="ptr6802-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ptr6802-cr-0005" contrib-type="author"><name><surname>Bhardwaj</surname><given-names>Mohit</given-names></name><xref ref-type="aff" rid="ptr6802-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ptr6802-cr-0006" contrib-type="author" corresp="yes"><name><surname>Patel</surname><given-names>Ashok K.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6134-7794</contrib-id><xref ref-type="aff" rid="ptr6802-aff-0001">
<sup>1</sup>
</xref><address><email>ashokpatel@bioschool.iitd.ac.in</email></address></contrib></contrib-group><aff id="ptr6802-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Kusuma School of Biological Sciences</named-content>
<institution>Indian Institute of Technology Delhi</institution>
<city>New Delhi</city>
<country country="IN">India</country>
</aff><aff id="ptr6802-aff-0002">
<label><sup>2</sup></label>
<institution>Morarji Desai National Institute of Yoga</institution>
<city>New Delhi</city>
<country country="IN">India</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Ashok K. Patel, Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi 110016, India.<break/>
Email: <email>ashokpatel@bioschool.iitd.ac.in</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>8</month><year>2020</year></pub-date><elocation-id>10.1002/ptr.6802</elocation-id><history><date date-type="received"><day>11</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>10</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>6</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 John Wiley & Sons, Ltd. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 John Wiley &#x00026; Sons, Ltd.</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:PTR-9999-na.pdf"/><abstract><p>The COVID&#x02010;19 disease caused by the SARS&#x02010;CoV&#x02010;2 has emerged as a worldwide pandemic and caused huge damage to the lives and economy of more than hundred countries. As on May 10, 2020, more than 4,153,300 people stand infected from the virus due to an unprecedented rate of transmission and 282,700 have lost their lives because of the disease. In this context, medicinal plants may provide a way to treat the disease by targeting specific essential proteins of the virus. We screened about 51 medicinal plants and found that Tea (<italic>Camellia sinensis)</italic> and Haritaki (<italic>Terminalia chebula</italic>) has potential against SARS&#x02010;COV&#x02010;2 3CL<sup>pro</sup>, with an IC<sub>50</sub> for Green Tea as 8.9&#x02009;&#x000b1;&#x02009;0.5 &#x003bc;g/ml and Haritaki 8.8&#x02009;&#x000b1;&#x02009;0.5 &#x003bc;g/ml. The in&#x02010;silico studies suggested that Tea component Thearubigins binds to the cysteine 145 of protease active site and could be a pharmacoactive molecule. We predict that the inhibition in protease activity may be able to halt the SARS&#x02010;CoV&#x02010;2 replication cycle and therefore, we propose Green Tea, Black Tea, and Haritaki plant extracts as potential therapeutic candidates for SARS&#x02010;CoV&#x02010;2 infection. Further investigation on role of bioactive constituents of extracts is needed to establish the molecular basis of inhibition and towards expedited drug discovery.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ptr6802-kwd-0001">3CL<sup>pro</sup></kwd><kwd id="ptr6802-kwd-0002">Haritaki</kwd><kwd id="ptr6802-kwd-0003">medicinal plants</kwd><kwd id="ptr6802-kwd-0004">SARS&#x02010;CoV&#x02010;2</kwd><kwd id="ptr6802-kwd-0005">tea</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Indian Institute of Technology Delhi </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100007488</institution-id></institution-wrap></funding-source><award-id>MI02217G</award-id></award-group></funding-group><counts><fig-count count="6"/><table-count count="1"/><page-count count="9"/><word-count count="5348"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.7 mode:remove_FC converted:19.08.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="self-citation" id="ptr6802-cit-9001">
<string-name>
<surname>Upadhyay</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tripathi</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Raghavendhar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bhardwaj</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>AK</given-names>
</string-name>. <article-title>Evaluation of medicinal herbs as a potential therapeutic option against <styled-content style="fixed-case" toggle="no">SARS&#x02010;CoV</styled-content>&#x02010;2 targeting its main protease</article-title>. <source xml:lang="en">Phytotherapy Research</source>. <year>2020</year>;<fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.6802</pub-id>
</mixed-citation>
</p><fn-group id="ptr6802-ntgp-0001"><fn id="ptr6802-note-0001"><p>Saurabh Upadhyay, Praveen K. Tripathi, and Manju Singh authors are provided equal contribution.</p></fn><fn id="ptr6802-note-1002"><p>
<bold>Funding information</bold> Indian Institute of Technology Delhi, Grant/Award Number: MI02217G</p></fn></fn-group></notes></front><body id="ptr6802-body-0001"><sec id="ptr6802-sec-0001"><label>1</label><title>INTRODUCTION</title><p>Coronavirus disease 2019 (COVID&#x02010;19) originated from Wuhan, China, has recently emerged as a global pandemic and a serious blow to human life and economy. The etiological agent of the disease is a positive&#x02010;sense single&#x02010;stranded RNA virus that belongs to the <italic>Coronaviridae</italic> family. Phylogenetically, the virus relates to the SARS&#x02010;CoV that emerged in 2002 and hence been named as the SARS&#x02010;CoV&#x02010;2 (Gorbalenya et al., <xref rid="ptr6802-bib-0014" ref-type="ref">2020</xref>). The COVID&#x02010;19 is characterized by the serious illness such as pneumonia and even respiratory failure in extreme cases (Chan et al., <xref rid="ptr6802-bib-0007" ref-type="ref">2020</xref>) among other multiple effects which are being deciphered with each passing day. The disease transmission occurs via droplet means and upon infection it displays higher fatality rate in elderly and immunocompromised individuals. These group of sufferers have more chances of disease progression (Liu, Chen, Lin, &#x00026; Han, <xref rid="ptr6802-bib-0021" ref-type="ref">2020</xref>). The disease leaves lesions on lungs and has effects liver as well. These pathological manifestations effects the post&#x02010;infection physiology of internal organs (Xu, Liu, Lu, Yang, &#x00026; Zheng, <xref rid="ptr6802-bib-0027" ref-type="ref">2020</xref>).</p><p>The virus comprises 26 different proteins, which include 10 major structural proteins, namely the envelope (E), membrane (M), nucleocapsid (N), and the trimeric spike (S) proteins that are vital to the completion of its replication cycle. Further, the viral genome encodes two proteases&#x02010; the papain&#x02010;like protease (PL<sup>pro</sup>); and the 3&#x02010;chymotrypsin&#x02010;like protease (3CL<sup>pro</sup>) also known as the main protease (M<sup>pro</sup>) of the virus (Anand, Ziebuhr, Wadhwani, Mesters, &#x00026; Hilgenfeld, <xref rid="ptr6802-bib-0001" ref-type="ref">2003</xref>). Both of the proteases are essential for the processing of polyproteins PP1A and PP1B, translated from the RNA of the virus (Hilgenfeld, <xref rid="ptr6802-bib-0015" ref-type="ref">2014</xref>) and the 3CL<sup>pro</sup> enzyme has emerged as an interesting premise for the development of drugs targeting the virus. The 3CL<sup>pro</sup> is very important for virus to replicate and propagate and its inhibitors may halt the disease at an early stage of replication. It recognises and cleaves the virus non&#x02010;structural polyprotein at 12 sites. One of the site on the polyprotein includes Leu&#x02010;Gln*(Ser, Ala, Gly) (* denotes the cleavage site). To impede virus replication, multiple strategies are being employed. Medicinal plants could be harnessed as one of the safest means of medication and have been used traditionally for various manifestations. The anti&#x02010;viral activities of several plants have been elucidated so far (Newman &#x00026; Cragg, <xref rid="ptr6802-bib-0023" ref-type="ref">2007</xref>). The role of plant lectins as anti&#x02010;SARS&#x02010;CoV&#x02010;2 has been proposed (Capell et al., <xref rid="ptr6802-bib-0004" ref-type="ref">2020</xref>). We have shortlisted the medicinal plants which are reported to possess the anti&#x02010;viral, anti&#x02010;oxidant, and anti&#x02010;inflammatory properties. Further, the aqueous extracts were screened for 3CL<sup>pro</sup> inhibition, in&#x02010;vitro. We found that tea (<italic>Camellia sinensis</italic>) and Haritaki (<italic>Terminalia chebula</italic>) as potential inhibitors of 3CL<sup>pro</sup> activity of SARS&#x02010;CoV&#x02010;2. Additonally, we compared the activity inhibition by different types of Teas and found that Green Tea and Black Tea displayed comparable potencies to inhibit the 3CL<sup>pro</sup> activity of SARS&#x02010;CoV&#x02010;2.</p><p>The pharmacoactive molecules like catechins, present in Green Tea, have been shown to possess multiple health&#x02010;boosting activities like hypoglycemic, hypotensive, anti&#x02010;tumor, anti&#x02010;oxidative, hypolipidemic, anti&#x02010;bacterial, and anti&#x02010;viral effects (Cabrera, Artacho, &#x00026; Gim&#x000e9;nez, <xref rid="ptr6802-bib-0003" ref-type="ref">2006</xref>; Cooper, Morr&#x000e9;, &#x00026; Morr&#x000e9;, <xref rid="ptr6802-bib-0010" ref-type="ref">2005a</xref>, <xref rid="ptr6802-bib-0011" ref-type="ref">2005b</xref>; Mahmood et al., <xref rid="ptr6802-bib-0022" ref-type="ref">2016</xref>). The (&#x02212;)&#x02010;Epigallocatechin gallate (EGCG) present in Green Tea has a virucidal effect on the Zika virus (Carneiro, Batista, Braga, Nogueira, &#x00026; Rahal, <xref rid="ptr6802-bib-0005" ref-type="ref">2016</xref>). Similarly, the Prodelphinidin B&#x02010;2 3&#x02032;&#x02010;<italic>O</italic>&#x02010;Gallate molecule has shown an anti&#x02010;viral effect against the Herpes Simplex Virus type 2 (HSV&#x02010;2; Cheng, Lin, &#x00026; Lin, <xref rid="ptr6802-bib-0009" ref-type="ref">2002</xref>). Further, the Green Tea extract has also been demonstrated as a safe personal hygiene option against viral infections like human influenza A/H1N1 virus (Lee, Jang, Kim, Kim, &#x00026; Seong, <xref rid="ptr6802-bib-0019" ref-type="ref">2018</xref>). Interestingly, Theaflavin&#x02010;3, 3&#x02032;&#x02010;digallate (TF3) which is produced from polymerization and oxidization of the epicatechin gallate and EGCG during fermentation of fresh Tea leaves, displayed 3CL<sup>pro</sup> inhibition (Chen et al., <xref rid="ptr6802-bib-0008" ref-type="ref">2005</xref>). Similarly, Haritaki is also believed to possess anti&#x02010;bacterial and anti&#x02010;viral activities (Lee et al., <xref rid="ptr6802-bib-0018" ref-type="ref">2011</xref>). Furthermore, it has been reported beneficial against viruses like HSV&#x02010;2 (Kesharwani et al., <xref rid="ptr6802-bib-0017" ref-type="ref">2017</xref>) and Influenza A virus (Li et al., <xref rid="ptr6802-bib-0020" ref-type="ref">2020</xref>). Epigallocathechin&#x02010;3&#x02010;gallate present in the <italic>C. sinensis</italic> inhibited the replication of hepatitis&#x02010;B virus (Karamese, Aydogdu, Karamese, Altoparlak, &#x00026; Gundogdu, <xref rid="ptr6802-bib-0016" ref-type="ref">2015</xref>). We assessed the proteolytic activity of the 3CL<sup>pro</sup> protein and found that the extracts of Tea (Green Tea and Black Tea) and Haritaki displayed a significant reduction in proteolytic activity.</p></sec><sec id="ptr6802-sec-0002"><label>2</label><title>MATERIALS AND METHODS</title><sec id="ptr6802-sec-0003"><label>2.1</label><title>Cloning and expression of main protease <styled-content style="fixed-case" toggle="no">3CL<sup>pro</sup></styled-content>
</title><p>The 3CL<sup>pro</sup> gene (Wuhan&#x02010;Hu&#x02010;1, NC_045512.2, region 10,055&#x02013;10,972) which is 918 base pair synthesized in pEXA2 vector was procured from Eurofins Genomics, Japan and was used for sub cloning in protein expression vector since it has been designed with BamHI and XhoI restriction enzyme sites. The digested desired gene insert was purified and ligated to a modified pET&#x02010;28a vector between BamHI and XhoI sites. This modified vector contains the sequences coding for PreScission, flag tag, and hexahistidine. The cloned gene in the pET&#x02010;28a vector was subjected to protein expression. After analyzing the soluble expressions from various expressing strains of <italic>Escherichia coli</italic>, we chose BL&#x02010;21DE3 Rosetta RIL cells for expressing the protein. The 3CL<sup>pro</sup> protein tagged with 6&#x02010;histidines at N&#x02010;terminal end was expressed using an auto&#x02010;induction method of protein production with appropriate antibiotics kanamycin (50&#x02009;&#x003bc;g/ml) and chloramphenicol (34&#x02009;&#x003bc;g/ml; Studier, <xref rid="ptr6802-bib-0025" ref-type="ref">2005</xref>). The cells were first cultured for 2 hr at +37&#x000b0;C, further grown at +18&#x000b0;C for 18&#x02009;hr. The cells were harvested by centrifugation, and the pellet was re&#x02010;suspended in buffer A (50&#x02009;mM Tris pH 7.5, 500&#x02009;mM NaCl, 10% glycerol, 10&#x02009;mM Imidazole) containing protease inhibitors 1&#x02009;mM DTT, 0.5&#x02009;mM PMSF and DNAseI 0.001&#x02009;mg/ml with 5&#x02009;mM MgCl<sub>2</sub>. The cells were lysed by adding lysozyme having final concentration 1 mg/ml and disrupted by sonication on ice with 30&#x02009;s ON and 30&#x02009;s OFF for 10 min, and the lysate was clarified by centrifugation at 10,000<italic>g</italic> for 30&#x02009;min. The clear lysate was applied onto a Ni&#x02010;NTA column pre&#x02010;equilibrated with buffer A on &#x000c4;KTA&#x02122; start FPLC system (GE Healthcare). The column was washed with 100&#x02009;mL of Buffer A, and 3CL<sup>pro</sup> protein was eluted with gradient elution 0&#x02013;500&#x02009;mM imidazole in buffer A. The fractions were analyzed on SDS&#x02010;PAGE for purity. The eluted fractions were pooled, dialyzed, and purified through QFF anion exchange chromatography with a linear gradient of NaCl (0&#x02013;500&#x02009;mM). The purified protein was homogeneous with about &#x0003e;95% purity and confirmed with western blot analysis. Fractions containing 3CL<sup>pro</sup> protein were pooled and cleaved with recombinant Precision protease at +4&#x000b0;C overnight. The overnight cleaved protein was reapplied on the Ni&#x02010;NTA column and the unbound sample has been collected. It was concentrated, buffer exchanged (20&#x02009;mM Tris HCl pH 7.5, 150&#x02009;mM NaCl, 10% Glycerol, and 1&#x02009;mM DTT), flash frozen and stored at &#x02212;80&#x000b0;C for all biochemical and biophysical studies.</p></sec><sec id="ptr6802-sec-0004"><label>2.2</label><title>Screening and preparation of plant extracts</title><p>The extensive review of scientific and Ayurvedic literature provided the basis of selection of plants having anti&#x02010;oxidant, anti&#x02010;inflammatory, anti&#x02010;viral, and other fortifying characteristics. All plants used in the study were supplied by an Ayurvedic physician at Morarji Desai National Institute of Yoga, New Delhi, India. Two grams of crude plants were powdered and dissolved in 10 mL de&#x02010;ionized water. The extraction of pharmacoactive compounds was done by keeping the aqueous extracts at 50&#x000b0;C for 12&#x02009;hr. The resultant suspension was centrifuged at 4,000<italic>g</italic> for 10 min, the supernatant was collected and kept for drying in petridish at 42&#x000b0;C for 24&#x02009;hr. The dried plant extracts powder was weighed and re&#x02010;dissolved at a concentration of 100&#x02009;mg/ml in de&#x02010;ionized water and 10 &#x003bc;L aliquots (1 mg per tube) was stored in &#x02212;20&#x000b0;C (Raghavendhar, Tripati, Ray, &#x00026; Patel, <xref rid="ptr6802-bib-0024" ref-type="ref">2019</xref>). In each experiments, the dilutions were freshly made as desired concentration of 1 mg/ml and used only once.</p></sec><sec id="ptr6802-sec-0005"><label>2.3</label><title>Establishment of protease activity using purified <styled-content style="fixed-case" toggle="no">3CL<sup>pro</sup></styled-content> and casein substrate</title><p>The protease activity of the purified 3CL<sup>pro</sup> was tested using a modified protocol from previously reported protocol using casein as a substrate (Banik, Biswas, &#x00026; Karmakar, <xref rid="ptr6802-bib-0002" ref-type="ref">2018</xref>; Cupp&#x02010;Enyard, <xref rid="ptr6802-bib-0013" ref-type="ref">2008</xref>). The 3CL<sup>pro</sup> enzyme is non&#x02010;specific as it cleaves at 12 different locations in SARS&#x02010;CoV&#x02010;2. Casein substrate contains peptide sequences that can be cleaved by 3CL<sup>pro</sup> of SARS&#x02010;CoV&#x02010;2. Hence, we have used the casein substrate for activity measurements. The substrate stock of 0.65% (274&#x02009;&#x003bc;M) was prepared in phosphate buffer pH 7.4 and the enzyme (3CL<sup>pro</sup>) was taken in varying concentrations. The 3CL<sup>pro</sup> enzyme (10 &#x003bc;M) and varying casein substrate (0&#x02013;257&#x02009;&#x003bc;M) were mixed to a final volume of 400&#x02009;&#x003bc;l and incubated at 37&#x000b0;C for an hour. After the incubation period reaction was stopped by adding 200&#x02009;&#x003bc;l of 110&#x02009;mM trichloroacetic acid (TCA) for 10 min. The final reaction mixture was then centrifuged for 10 min at 15,000<italic>g</italic> and absorbance at OD<sub>280</sub> was measured using a spectrometer (Beckman Coulter DU 800 spectrophotometer) and values of reactions were subtracted with that of the buffer. The absorbance at 280&#x02009;nm is the measurement of <sc>l</sc>&#x02010;tyrosine produced by the protease activity. The standard plot of <sc>l</sc>&#x02010;tyrosine was plotted for the velocity calculations. The maximum velocity of the enzymatic reaction was calculated using substrate concentration versus velocity plot and fitted with Michaelis&#x02013;Menten equations.</p></sec><sec id="ptr6802-sec-0006"><label>2.4</label><title>Evaluation of protease inhibition by plant extracts</title><p>The plants aqueous extracts were evaluated for their potential to inhibit the enzyme activity. The 10 &#x003bc;M of 3CL<sup>pro</sup> enzyme and 137&#x02009;&#x003bc;M of casein substrate were used to study the inhibition effects of extracts. Different concentrations (0&#x02013;450&#x02009;&#x003bc;g/ml) of extracts were screened to assess their inhibitory potential. Two sets of reactions were prepared, one for reaction with extracts having 3CL<sup>pro</sup> and another without 3CL<sup>pro</sup>, as control. The rate of inhibition and potential efficacy was calculated by standard kinetics curve.</p></sec><sec id="ptr6802-sec-0007"><label>2.5</label><title>Biomolecular interaction studies using an intrinsic fluorescence assay</title><p>Fluorescence quenching was performed to analyze the effect of plants extracts on the 3CL<sup>pro</sup> structural dynamics. The tertiary structure perturbations post&#x02010;interaction to ligands present in the extracts were assessed using intrinsic fluorescence of 3CL<sup>pro</sup>. Ten &#x003bc;M of 3CL<sup>pro</sup> protein was incubated with or without extracts at different concentrations (0&#x02013;80&#x02009;&#x003bc;g/ml), fluorescence intensity was monitored on Cary Eclipse fluorescence spectrophotometer (Agilent technologies). The parameters used for excitation wavelength is 295&#x02009;nm and emission scan between 310 and 400&#x02009;nm with the slit width for excitation (5 nm) and emission (10 nm). The experiments were performed at controlled temperature 25&#x000b0;C. The change in intensity or wavelength was used for the protein ligand interaction analysis.</p></sec><sec id="ptr6802-sec-0008"><label>2.6</label><title>Comparative protease inhibition study of Green Tea, Black Tea, and Haritaki</title><p>To decipher the difference in efficacies to inhibit the viral protease by universally used Tea, we compared the enzymatic inhibition for Green Tea as wells as Black Tea mentioned above using the 10 &#x003bc;M of 3CL<sup>pro</sup> at varying concentrations of Tea. Moreover, we have analyzed the effective protease inhibition by both tea with Haritaki. All the parameters like substrate, enzyme, and inhibitor concentrations were kept constant during the reactions.</p></sec><sec id="ptr6802-sec-0009"><label>2.7</label><title>Docking studies of abundantly present active molecules</title><p>The crystal structure PDB 6LU7 of the 3CL<sup>pro</sup> was taken from the RCSB databank. The active site prediction was performed using the metaPocket2.0 server and the best hit near to catalytic site having His41 and Cys145 was fixed. This was used for site&#x02010;specific docking using ParDock software. The 3&#x02010;dimensional structures of active compounds present in the medicinal plants were taken from the PubChem database. The docking results were analyzed based on binding energy and binding poses.</p></sec></sec><sec id="ptr6802-sec-0010"><label>3</label><title>RESULTS</title><sec id="ptr6802-sec-0011"><label>3.1</label><title>Cloning and expression of <styled-content style="fixed-case" toggle="no">3CL<sup>pro</sup></styled-content>
</title><p>The gene encoding 3CL<sup>pro</sup> was cloned in pET&#x02010;28a vector having 6x His, FLAG (DYKDDDDK) sequence and PreScission cleavage (LEVLFQGP) sequence. The cloning was successfully done, the double digested product of the expected size of nearly 5.4 kb and 918&#x02009;bp for vector and insert, respectively (Figure <xref rid="ptr6802-fig-0001" ref-type="fig">1A</xref>).</p><fig fig-type="FIGURE" xml:lang="en" id="ptr6802-fig-0001" orientation="portrait" position="float"><label>FIGURE 1</label><caption><p>Cloning and purification of 3CL<sup>pro</sup> protein. (A) 1% agarose gel showing the bands of the double digested plasmid with vector 5.4 kb and insert around 918 bases (L2), the cloned plasmid showing band at 6.4 kb (L3). (B) SDS&#x02010;PAGE on 12% acrylamide gel, depicting homogenous protein at ~34&#x02009;kDa (C) The western blot of purified 3CL<sup>pro</sup> using anti&#x02010;His antibody with mol wt ~34&#x02009;kDa (L2) [Colour figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>]</p></caption><graphic id="nlm-graphic-1" xlink:href="PTR-9999-na-g001"/></fig><p>The 3CL<sup>pro</sup> was expressed in <italic>E. coli</italic> expression system and purified to homogeneity with affinity and anion exchange chromatography (Figure <xref rid="ptr6802-fig-0001" ref-type="fig">1B</xref>). The confirmation of the protein was done using western blot analysis using anti&#x02010;His antibody (Figure <xref rid="ptr6802-fig-0001" ref-type="fig">1C</xref>).</p></sec></sec><sec id="ptr6802-sec-0012"><label>4</label><title>ESTIMATION OF ENZYME PARAMETERS BY CASEIN&#x02010;BASED PROTEASE ASSAY</title><p>The activity assay to validate the enzymatic property of recombinantly purified 3CL<sup>pro</sup> was established by using the casein substrate. The calculation of <italic>K</italic>
<sub><italic>m</italic></sub> for casein was performed by the varying casein substrate and it was obtained as 137&#x02009;&#x003bc;M (Figure <xref rid="ptr6802-fig-0002" ref-type="fig">2</xref>).</p><fig fig-type="FIGURE" xml:lang="en" id="ptr6802-fig-0002" orientation="portrait" position="float"><label>FIGURE 2</label><caption><p>Enzyme kinetic studies of 3CL<sup>pro</sup>. (A) Evaluation of kinetic parameters in Michaelis&#x02013;Menten fit. The varying concentration of the casein substrate (<italic>x</italic>&#x02010;axis) plotted against the velocity (<italic>y</italic>&#x02010;axis). (B) Inverse substrate versus inverse velocity plot (Lineweaver&#x02013;Burk plot) depicting the casein substrate cleavage by the action of 3CL<sup>pro</sup>. All the experiments were performed in triplicates [Colour figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>]</p></caption><graphic id="nlm-graphic-3" xlink:href="PTR-9999-na-g002"/></fig><sec id="ptr6802-sec-0013"><label>4.1</label><title>Inhibition of <styled-content style="fixed-case" toggle="no">3CL<sup>pro</sup></styled-content> enzyme by plant extracts</title><p>The plant extracts were screened for protease activity and inhibition potential is shown in Table <xref rid="ptr6802-tbl-0001" ref-type="table">1</xref>. Results shown a significant reduction in protease activity of 3CL<sup>pro</sup> by Green Tea (<italic>C. sinensis</italic>) and Haritaki (<italic>T. chebula</italic>).</p><table-wrap id="ptr6802-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>List of medicinal plants screened for SARS&#x02010;CoV&#x02010;2 main protease 3CL<sup>pro</sup> inhibition</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">S.no</th><th align="left" valign="bottom" rowspan="1" colspan="1">Plants common name</th><th align="left" valign="bottom" rowspan="1" colspan="1">Plants scientific name</th><th align="left" valign="bottom" rowspan="1" colspan="1">Part used</th><th align="left" valign="bottom" rowspan="1" colspan="1">% activity inhibition at 100&#x02009;&#x003bc;g/ml of aqueous extract</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Aloe vera</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Aloe barbadensis miller</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">Amala</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Phyllanthus emblica</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">Anise</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Pimpinella anisum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">Antmul</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Tylophora indica</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">Bael</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Aegle marmelos</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Pulp of fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">Ber</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Ziziphus mauritiana</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">Bhilawa</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Semecarpusana cardium</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">Bhojpatra</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Betula utilis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">Black tea</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Camellia sinensis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">100%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">Chirata</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Swertia chirayita</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf and stem</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">Chopachini</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Smilax glabra</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Rhizome</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">Cinnamon</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Cinnamomum verum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Bark</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">Coconut</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Cocos nucifera</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Husk fiber</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">Daaruharidra</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Berberi saristata</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Stem</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">Deodar</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Cedrus deodara</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Bark</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">Elaichi</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Elettaria cardamomum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">Fennel</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Foeniculum vulgare</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">Fenugreek</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Trigonella foenum&#x02010;graecum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="left" valign="top" rowspan="1" colspan="1">Garlic</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Allium sativum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Clove</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">Giloy</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Tinospora cordifolia</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Stem</td><td align="left" valign="top" rowspan="1" colspan="1">13%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">Ginger</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Zingiber officinale</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Rhizome</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="left" valign="top" rowspan="1" colspan="1">Gojihva</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Onosma bracteatum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf and stem</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1">Green tea</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Camellia sinensis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">100%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">24</td><td align="left" valign="top" rowspan="1" colspan="1">Guggul</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Commiphora wightii</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Resin</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">8%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">Haridra</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Curcuma longa</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Rhizome</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">Haritaki</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Terminali achebula</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Fruit</td><td align="left" valign="top" rowspan="1" colspan="1">100%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">27</td><td align="left" valign="top" rowspan="1" colspan="1">Kachur</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Curcuma zedoaria</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Rhizome</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">28</td><td align="left" valign="top" rowspan="1" colspan="1">Kalmegh</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Andrographis paniculata</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">29</td><td align="left" valign="top" rowspan="1" colspan="1">Kantakari</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Solanum surratense</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">Lemon</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Citrus Limon</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">31</td><td align="left" valign="top" rowspan="1" colspan="1">Mamira</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Coptis teeta</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">32</td><td align="left" valign="top" rowspan="1" colspan="1">Maricha</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Piper nigrum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">33</td><td align="left" valign="top" rowspan="1" colspan="1">Mulethi</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Glycyrrhiza glabra</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Root</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">40%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="left" valign="top" rowspan="1" colspan="1">Musta</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Cyperus rotundus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Rhizome</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">35</td><td align="left" valign="top" rowspan="1" colspan="1">Nimba</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Azadirachta indica</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">15%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="left" valign="top" rowspan="1" colspan="1">Nirgundi</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Vitex negundo</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">37</td><td align="left" valign="top" rowspan="1" colspan="1">Pippali</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Piper longum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">Puskarmool</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Inulara cemosa</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Root</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">Rasna</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Pluchea lanceolate</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf, stem</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">Sallaki</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Boswellia serrata</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Resin</td><td align="left" valign="top" rowspan="1" colspan="1">12%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">41</td><td align="left" valign="top" rowspan="1" colspan="1">Shalparni</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Desmodium gangeticum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Root</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">42</td><td align="left" valign="top" rowspan="1" colspan="1">Shatavari</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Asparagus racemosus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Rhizome</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">43</td><td align="left" valign="top" rowspan="1" colspan="1">Shleshmatak</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Cordia dichotoma</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Fruit</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">44</td><td align="left" valign="top" rowspan="1" colspan="1">Spirulina</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Arthrospira platensis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Entire plant</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">45</td><td align="left" valign="top" rowspan="1" colspan="1">Sunthi</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Zingiber officinale</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Rhizome</td><td align="left" valign="top" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="left" valign="top" rowspan="1" colspan="1">Surajmukhi beej</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Helianthus annuus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Seed</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">Suranjaan</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Colchicum luteum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Rhizome</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">48</td><td align="left" valign="top" rowspan="1" colspan="1">Talispatra</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Abies webbiana</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">49</td><td align="left" valign="top" rowspan="1" colspan="1">Tilpushpi</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Digitalis purpurea</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">50</td><td align="left" valign="top" rowspan="1" colspan="1">Tulsi</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Ocimum sanctum</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Leaf</td><td align="left" valign="top" rowspan="1" colspan="1">20%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">51</td><td align="left" valign="top" rowspan="1" colspan="1">Vasaka</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Adhatoda vasica</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Leaf</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr></tbody></table></table-wrap><p>The IC<sub>50</sub> values of Green Tea and Haritaki was found to be 8.9 &#x000b1;&#x02009;0.5 and 8.8 &#x000b1;&#x02009;0.5 &#x003bc;g/ml, respectively (Figure <xref rid="ptr6802-fig-0003" ref-type="fig">3</xref>). The aqueous extracts of plants Mulethi (<italic>Glycyrrhiza glabra</italic>), Tulsi (<italic>Ocimum tenuiflorum</italic>), Giloy (<italic>Tinospora cordifolia</italic>), and Neem (<italic>Azadirachta indica</italic>) have less efficiency in inhibiting the protease activity of 3CL<sup>pro</sup>. These plants could not inhibit the 3CL<sup>pro</sup> protease activity to 50% even with 450&#x02009;&#x003bc;g/ml of the plant extracts.</p><fig fig-type="FIGURE" xml:lang="en" id="ptr6802-fig-0003" orientation="portrait" position="float"><label>FIGURE 3</label><caption><p>Determination of inhibitory concentration of plant extracts. The inhibition of percentage enzyme activity in the presence of varying concentrations (0&#x02013;450&#x02009;&#x003bc;g/ml) of plant extracts are shown. The value at which the 50% enzyme activity&#x02010;reduction observed is taken as IC<sub>50</sub> of individual extracts. All the experiments were performed in triplicates. Error bars represent SEM [Colour figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>]</p></caption><graphic id="nlm-graphic-5" xlink:href="PTR-9999-na-g003"/></fig></sec><sec id="ptr6802-sec-0014"><label>4.2</label><title>Evaluation of tertiary structure changes in <styled-content style="fixed-case" toggle="no">3CL<sup>pro</sup></styled-content> post&#x02010;interaction to plant extracts</title><p>The interactions of the active moieties present in the extracts interacted with the 3CL<sup>pro</sup> protein and resulted in the tertiary structure perturbation. The fluorescence quenching was observed as depicted by the decrease in the intensity of the fluorescence spectra (Figure <xref rid="ptr6802-fig-0004" ref-type="fig">4</xref>).</p><fig fig-type="FIGURE" xml:lang="en" id="ptr6802-fig-0004" orientation="portrait" position="float"><label>FIGURE 4</label><caption><p>Estimation of tertiary structure perturbation in the presence of plant extracts. (A) Titration of 3CL<sup>pro</sup> with varying concentrations of Green Tea <italic>(Camellia sinensis)</italic>. (B) Titration of 3CL<sup>pro</sup> with varying concentrations of Haritaki (<italic>Terminalia chebula)</italic> [Colour figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>]</p></caption><graphic id="nlm-graphic-7" xlink:href="PTR-9999-na-g004"/></fig></sec><sec id="ptr6802-sec-0015"><label>4.3</label><title>Comparative protease inhibition activity of Green Tea, Black Tea, and Haritaki</title><p>The comparison in the 3CL<sup>pro</sup> protease inhibition efficacies of Green Tea, Black Tea, and Haritaki were studied. Both Tea (Green Tea and Black tea) and Haritaki displayed comparable inhibition to protease activity; 50% inhibition at 10 &#x003bc;g/ml and more than 90% inhibition beyond 40&#x02009;&#x003bc;g/ml. The results suggest that either form of Tea and Haritaki can be a potential anti&#x02010;viral agent against the SARS&#x02010;CoV&#x02010;2 (Figure <xref rid="ptr6802-fig-0005" ref-type="fig">5</xref>).</p><fig fig-type="FIGURE" xml:lang="en" id="ptr6802-fig-0005" orientation="portrait" position="float"><label>FIGURE 5</label><caption><p>The comparison of inhibitory potential between Green Tea, Black Tea, and Haritaki towards 3CL<sup>pro</sup> activity inhibition. The graph represents the activity inhibition by Green Tea, Black Tea, and Haritaki. All the experiments were performed in triplicates and error bars represent SEM [Colour figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>]</p></caption><graphic id="nlm-graphic-9" xlink:href="PTR-9999-na-g005"/></fig></sec><sec id="ptr6802-sec-0016"><label>4.4</label><title>Deciphering molecular insights through an in&#x02010;silico approach</title><p>The key residues of the active site are histidine 41 and cysteine 145. The active site&#x02010;specific docking revealed the binding of thearubigin, a compound present in Tea. The binding energy of the molecule was found to be &#x02212;8.53&#x02009;kcal/mol. It displayed direct interaction with the cysteine 145 of the active site. Another molecule, quercetin&#x02010;3&#x02010;O&#x02010;rutinoside present in Tea, shown to form extensive hydrogen bonding with the residues of the active site pocket. The amino acid residues involved in the bi&#x02010;molecular interactions include leucine 141, asparagine 142, glycine 143, and glutamine 166. The docking energy for this interaction was found to be &#x02212;7.73&#x02009;kcal/mol. Within the range of 4 &#x000c5;, the hesperidin displayed hydrophobic interaction with methionine 165 and glutamine 189 and hydrogen bonding with asparagine 142 and glycine 146. The binding for this interaction was &#x02212;7.46&#x02009;kcal/mol.</p></sec></sec><sec id="ptr6802-sec-0017"><label>5</label><title>DISCUSSION</title><p>The COVID&#x02010;19 disease has garnered immediate attention from scientists and medical experts worldwide. The hunt for an effective therapy and potential intervention against SARS&#x02010;CoV&#x02010;2 has become a primary goal. In this context, we report medicinal plant extracts from Tea (Green Tea and Black Tea) and Haritaki as potential therapeutic options for the management of infection. The Ab&#x02010;Initio drug discovery programs require huge capital investment and some undesirous events like immunogenicity, toxicity, and efficacy remain a matter of concern in the clinical trials (Corsello et al., <xref rid="ptr6802-bib-0012" ref-type="ref">2017</xref>). We harnessed principle of medicinal plants to tackle the challenge of COVID&#x02010;19. The present study screened 51 plants having anti&#x02010;viral potential against the main protease of SARS&#x02010;CoV&#x02010; 2. The study reveals the inhibitory potential of Tea and Haritaki against 3CL<sup>pro</sup>; a crucial enzymatic protein of SARS&#x02010;CoV&#x02010;2 (Anand et al., <xref rid="ptr6802-bib-0001" ref-type="ref">2003</xref>). The halt in this enzymatic activity can potentially block the replication of the virus inside the cells and may confer a protective effect in COVID&#x02010;19. The infection of the SARS&#x02010;CoV&#x02010;2 produces a wave of inflammatory mediators and manifests severe oxidative damage (Varga et al., <xref rid="ptr6802-bib-0026" ref-type="ref">2020</xref>). The inflammatory and oxidative damage to the cells conferred by the virus can be countered by the anti&#x02010;inflammatory and anti&#x02010;oxidative properties of these plants (Cabrera et al., <xref rid="ptr6802-bib-0003" ref-type="ref">2006</xref>; Chan, Lim, &#x00026; Chew, <xref rid="ptr6802-bib-0006" ref-type="ref">2007</xref>; Karamese et al., <xref rid="ptr6802-bib-0016" ref-type="ref">2015</xref>; Lee et al., <xref rid="ptr6802-bib-0019" ref-type="ref">2018</xref>). Also, as these plants are routinely used for treatment in different kinds of diseases and disorders, the risks of cytotoxic effects are also relatively low (Cheng et al., <xref rid="ptr6802-bib-0009" ref-type="ref">2002</xref>; Karamese et al., <xref rid="ptr6802-bib-0016" ref-type="ref">2015</xref>). The anti&#x02010;viral properties of Tea have been demonstrated against the influenza virus, zika virus, hepatitis&#x02010;B virus, and SARS virus (Carneiro et al., <xref rid="ptr6802-bib-0005" ref-type="ref">2016</xref>; Mahmood et al., <xref rid="ptr6802-bib-0022" ref-type="ref">2016</xref>).</p><p>We found that components present in the aqueous extract of Tea and Haritaki inhibited the 3CL<sup>pro</sup> of SARS&#x02010;CoV&#x02010;2 (Figure <xref rid="ptr6802-fig-0003" ref-type="fig">3</xref>). However, the anti&#x02010;viral effect of these extracts and bioactive constituents needs to be validated in the in&#x02010;vivo studies. The activity data (Figure <xref rid="ptr6802-fig-0005" ref-type="fig">5</xref>) suggests that both Tea and Haritaki might be good source for the design of potential inhibitors for the 3CL<sup>pro</sup> of SARS&#x02010;CoV&#x02010;2. We have tried to investigate the potential and probable molecules that are abundantly present in Tea. Among the virtually screened molecules, thearubigin, quercetin&#x02010;3&#x02010;O&#x02010;rutinoside, and hesperidin displayed interaction with the active site of the protease (Figure <xref rid="ptr6802-fig-0006" ref-type="fig">6</xref>). To our best, this is the first in&#x02010;vitro reporting and validation of the protease inhibition by Green Tea, Black Tea, and Haritaki extracts against 3CL<sup>pro</sup> of SARS&#x02010;CoV&#x02010;2. These findings lays the foundation for further analysis of active molecules and their validation in higher validation systems.</p><fig fig-type="FIGURE" xml:lang="en" id="ptr6802-fig-0006" orientation="portrait" position="float"><label>FIGURE 6</label><caption><p>Active site details and binding of thearubigin. (A) Structure of native 6LU7 (green) and bounded (yellow), the active site space determined by metapocket2.0 (MPT in magenta), and the active site residues His41 and Cys145. (B) 2&#x02010;D interaction diagram of thearubigin with the residues of the active site. The interaction profile of quercetin&#x02010;3&#x02010;O&#x02010;rutinoside (C), and hesperidin (D) [Colour figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>]</p></caption><graphic id="nlm-graphic-11" xlink:href="PTR-9999-na-g006"/></fig></sec><sec id="ptr6802-sec-0018"><label>6</label><title>CONCLUSION</title><p>We present the prospective therapeutic potential of the aqueous extracts of Tea (<italic>C. sinensis</italic>) and Haritaki (<italic>T. chebula)</italic> against SARS&#x02010;CoV&#x02010;2 based on 3CL<sup>pro</sup> protease activity inhibition. These herb extracts contain a plethora of molecules researched to have anti&#x02010;viral, anti&#x02010;inflammatory, anti&#x02010;oxidant properties, and other beneficial health effects. In the current scenario of pandemic, an expedited evaluation of bioactive constituents is required to establish the anti&#x02010;SARS&#x02010;CoV&#x02010;2 property of these herbs. Moreover, larger randomized, double&#x02010;blind, placebo&#x02010;controlled multicenter clinical trials should be conducted before incorporation of these herbs as a prospective therapeutic option.</p></sec><sec sec-type="COI-statement" id="ptr6802-sec-0020"><title>CONFLICT OF INTEREST</title><p>Authors declare no conflict of interest.</p></sec></body><back><ack id="ptr6802-sec-0019"><title>ACKNOWLEDGMENTS</title><p>The authors thanks IIT Delhi and Kusuma Trust for the infrastructure support. They acknowledge the funding support from the Dean, Research and Development, IIT Delhi, New Delhi, India through Grant No MI02217G.</p></ack><ref-list id="ptr6802-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="ptr6802-bib-0001"><mixed-citation publication-type="journal" id="ptr6802-cit-0001">
<string-name>
<surname>Anand</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Ziebuhr</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wadhwani</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Mesters</surname>, <given-names>J. R.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Hilgenfeld</surname>, <given-names>R.</given-names>
</string-name> (<year>2003</year>). <article-title>Coronavirus main proteinase (3CLpro) structure: Basis for design of anti&#x02010;SARS drugs</article-title>. <source xml:lang="en">Science</source>, <volume>300</volume>, <fpage>1763</fpage>&#x02013;<lpage>1767</lpage>. <pub-id pub-id-type="doi">10.1126/science.1085658</pub-id>
<pub-id pub-id-type="pmid">12746549</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0002"><mixed-citation publication-type="journal" id="ptr6802-cit-0002">
<string-name>
<surname>Banik</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Biswas</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Karmakar</surname>, <given-names>S.</given-names>
</string-name> (<year>2018</year>). <article-title>Extraction, purification, and activity of protease from the leaves of <italic>Moringa oleifera</italic>
</article-title>. <source xml:lang="en">F1000Research</source>, <volume>7</volume>, <fpage>1151</fpage>
<pub-id pub-id-type="doi">10.12688/f1000research.15642.1</pub-id>
<pub-id pub-id-type="pmid">30345026</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0003"><mixed-citation publication-type="journal" id="ptr6802-cit-0003">
<string-name>
<surname>Cabrera</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Artacho</surname>, <given-names>R.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Gim&#x000e9;nez</surname>, <given-names>R.</given-names>
</string-name> (<year>2006</year>). <article-title>Beneficial effects of green tea&#x02014;A review</article-title>. <source xml:lang="en">Journal of the American College of Nutrition</source>, <volume>25</volume>, <fpage>79</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1080/07315724.2006.10719518</pub-id>
<pub-id pub-id-type="pmid">16582024</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0004"><mixed-citation publication-type="journal" id="ptr6802-cit-0004">
<string-name>
<surname>Capell</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Twyman</surname>, <given-names>R. M.</given-names>
</string-name>, <string-name>
<surname>Armario&#x02010;Najera</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Ma</surname>, <given-names>J. K.&#x02010;C.</given-names>
</string-name>, <string-name>
<surname>Schillberg</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Christou</surname>, <given-names>P.</given-names>
</string-name> (<year>2020</year>). <article-title>Potential applications of plant biotechnology against SARS&#x02010;CoV&#x02010;2</article-title>. <source xml:lang="en">Trends in Plant Science</source>, <volume>0</volume>, <fpage>635</fpage>&#x02013;<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1016/j.tplants.2020.04.009</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0005"><mixed-citation publication-type="journal" id="ptr6802-cit-0005">
<string-name>
<surname>Carneiro</surname>, <given-names>B. M.</given-names>
</string-name>, <string-name>
<surname>Batista</surname>, <given-names>M. N.</given-names>
</string-name>, <string-name>
<surname>Braga</surname>, <given-names>A. C. S.</given-names>
</string-name>, <string-name>
<surname>Nogueira</surname>, <given-names>M. L.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Rahal</surname>, <given-names>P.</given-names>
</string-name> (<year>2016</year>). <article-title>The green tea molecule EGCG inhibits Zika virus entry</article-title>. <source xml:lang="en">Virology</source>, <volume>496</volume>, <fpage>215</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2016.06.012</pub-id>
<pub-id pub-id-type="pmid">27344138</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0006"><mixed-citation publication-type="journal" id="ptr6802-cit-0006">
<string-name>
<surname>Chan</surname>, <given-names>E. W. C.</given-names>
</string-name>, <string-name>
<surname>Lim</surname>, <given-names>Y. Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Chew</surname>, <given-names>Y. L.</given-names>
</string-name> (<year>2007</year>). <article-title>Antioxidant activity of <italic>Camellia sinensis</italic> leaves and tea from a lowland plantation in Malaysia</article-title>. <source xml:lang="en">Food Chemistry</source>, <volume>102</volume>, <fpage>1214</fpage>&#x02013;<lpage>1222</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2006.07.009</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0007"><mixed-citation publication-type="journal" id="ptr6802-cit-0007">
<string-name>
<surname>Chan</surname>, <given-names>J. F. W.</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kok</surname>, <given-names>K. H.</given-names>
</string-name>, <string-name>
<surname>To</surname>, <given-names>K. K. W.</given-names>
</string-name>, <string-name>
<surname>Chu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>J.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Yuen</surname>, <given-names>K. Y.</given-names>
</string-name> (<year>2020</year>). <article-title>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person&#x02010;to&#x02010;person transmission: A study of a family cluster</article-title>. <source xml:lang="en">The Lancet</source>, <volume>395</volume>, <fpage>514</fpage>&#x02013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30154-9</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0008"><mixed-citation publication-type="journal" id="ptr6802-cit-0008">
<string-name>
<surname>Chen</surname>, <given-names>C.&#x02010;N.</given-names>
</string-name>, <string-name>
<surname>Lin</surname>, <given-names>C. P. C.</given-names>
</string-name>, <string-name>
<surname>Huang</surname>, <given-names>K.&#x02010;K.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>W.&#x02010;C.</given-names>
</string-name>, <string-name>
<surname>Hsieh</surname>, <given-names>H.&#x02010;P.</given-names>
</string-name>, <string-name>
<surname>Liang</surname>, <given-names>P.&#x02010;H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Hsu</surname>, <given-names>J. T.&#x02010;A.</given-names>
</string-name> (<year>2005</year>). <article-title>Inhibition of SARS&#x02010;CoV 3C&#x02010;like protease activity by Theaflavin&#x02010;3,3&#x02032;&#x02010;digallate (TF3)</article-title>. <source xml:lang="en">Evidence&#x02010;Based Complementary and Alternative Medicine</source>, <volume>2</volume>, <fpage>209</fpage>&#x02013;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1093/ecam/neh081</pub-id>
<pub-id pub-id-type="pmid">15937562</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0009"><mixed-citation publication-type="journal" id="ptr6802-cit-0009">
<string-name>
<surname>Cheng</surname>, <given-names>H.&#x02010;Y.</given-names>
</string-name>, <string-name>
<surname>Lin</surname>, <given-names>C.&#x02010;C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Lin</surname>, <given-names>T.&#x02010;C.</given-names>
</string-name> (<year>2002</year>). <article-title>Antiviral properties of Prodelphinidin B&#x02010;2 3&#x02032;&#x02010;<italic>O</italic>&#x02010;Gallate from green tea leaf</article-title>. <source xml:lang="en">Antiviral Chemistry &#x00026; Chemotherapy</source>, <volume>13</volume>, <fpage>223</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1177/095632020201300403</pub-id>
<pub-id pub-id-type="pmid">12495210</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0010"><mixed-citation publication-type="journal" id="ptr6802-cit-0010">
<string-name>
<surname>Cooper</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Morr&#x000e9;</surname>, <given-names>D. J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Morr&#x000e9;</surname>, <given-names>D. M.</given-names>
</string-name> (<year>2005a</year>). <article-title>Medicinal benefits of green tea: Part I. review of noncancer health benefits</article-title>. <source xml:lang="en">Journal of Alternative and Complementary Medicine</source>, <volume>11</volume>, <fpage>521</fpage>&#x02013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1089/acm.2005.11.521</pub-id>
<pub-id pub-id-type="pmid">15992239</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0011"><mixed-citation publication-type="journal" id="ptr6802-cit-0011">
<string-name>
<surname>Cooper</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Morr&#x000e9;</surname>, <given-names>D. J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Morr&#x000e9;</surname>, <given-names>D. M.</given-names>
</string-name> (<year>2005b</year>). <article-title>Medicinal benefits of green tea: Part II. Review of anticancer properties</article-title>. <source xml:lang="en">Journal of Alternative and Complementary Medicine</source>, <volume>11</volume>, <fpage>639</fpage>&#x02013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1089/acm.2005.11.639</pub-id>
<pub-id pub-id-type="pmid">16131288</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0012"><mixed-citation publication-type="journal" id="ptr6802-cit-0012">
<string-name>
<surname>Corsello</surname>, <given-names>S. M.</given-names>
</string-name>, <string-name>
<surname>Bittker</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Gould</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>McCarren</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Hirschman</surname>, <given-names>J. E.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Golub</surname>, <given-names>T. R.</given-names>
</string-name> (<year>2017</year>). <article-title>The drug repurposing hub: A next&#x02010;generation drug library and information resource</article-title>. <source xml:lang="en">Nature Medicine</source>, <volume>23</volume>, <fpage>405</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4306</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0013"><mixed-citation publication-type="journal" id="ptr6802-cit-0013">
<string-name>
<surname>Cupp&#x02010;Enyard</surname>, <given-names>C.</given-names>
</string-name> (<year>2008</year>). <article-title>Sigma's non&#x02010;specific protease activity assay&#x02014;Casein as a substrate</article-title>. <source xml:lang="en">Journal of Visualized Experiments</source>, (<issue>19</issue>), <fpage>e899</fpage>
<pub-id pub-id-type="doi">10.3791/899</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0014"><mixed-citation publication-type="journal" id="ptr6802-cit-0014">
<string-name>
<surname>Gorbalenya</surname>, <given-names>A. E.</given-names>
</string-name>, <string-name>
<surname>Baker</surname>, <given-names>S. C.</given-names>
</string-name>, <string-name>
<surname>Baric</surname>, <given-names>R. S.</given-names>
</string-name>, <string-name>
<surname>de Groot</surname>, <given-names>R. J.</given-names>
</string-name>, <string-name>
<surname>Drosten</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Gulyaeva</surname>, <given-names>A. A.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Ziebuhr</surname>, <given-names>J.</given-names>
</string-name> (<year>2020</year>). <article-title>The species Severe acute respiratory syndrome&#x02010;related coronavirus: classifying 2019&#x02010;nCoV and naming it SARS&#x02010;CoV&#x02010;2</article-title>. <source xml:lang="en">Nature Microbiology</source>, <volume>5</volume>, <fpage>536</fpage>&#x02013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-020-0695-z</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0015"><mixed-citation publication-type="journal" id="ptr6802-cit-0015">
<string-name>
<surname>Hilgenfeld</surname>, <given-names>R.</given-names>
</string-name> (<year>2014</year>). <article-title>From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design</article-title>. <source xml:lang="en">The FEBS Journal</source>, <volume>281</volume>, <fpage>4085</fpage>&#x02013;<lpage>4096</lpage>. <pub-id pub-id-type="doi">10.1111/febs.12936</pub-id>
<pub-id pub-id-type="pmid">25039866</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0016"><mixed-citation publication-type="journal" id="ptr6802-cit-0016">
<string-name>
<surname>Karamese</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Aydogdu</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Karamese</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Altoparlak</surname>, <given-names>U.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Gundogdu</surname>, <given-names>C.</given-names>
</string-name> (<year>2015</year>). <article-title>Preventive effects of a major component of green tea, epigallocathechin&#x02010;3&#x02010;gallate, on hepatitis&#x02010;B virus DNA replication</article-title>. <source xml:lang="en">Asian Pacific Journal of Cancer Prevention</source>, <volume>16</volume>, <fpage>4199</fpage>&#x02013;<lpage>4202</lpage>. <pub-id pub-id-type="doi">10.7314/apjcp.2015.16.10.4199</pub-id>
<pub-id pub-id-type="pmid">26028072</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0017"><mixed-citation publication-type="journal" id="ptr6802-cit-0017">
<string-name>
<surname>Kesharwani</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Polachira</surname>, <given-names>S. K.</given-names>
</string-name>, <string-name>
<surname>Nair</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Agarwal</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Mishra</surname>, <given-names>N. N.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Gupta</surname>, <given-names>S. K.</given-names>
</string-name> (<year>2017</year>). <article-title>Anti&#x02010;HSV&#x02010;2 activity of <italic>Terminalia chebula</italic> Retz extract and its constituents, chebulagic and chebulinic acids</article-title>. <source xml:lang="en">BMC Complementary and Alternative Medicine</source>, <volume>17</volume>, <fpage>110</fpage>
<pub-id pub-id-type="doi">10.1186/s12906-017-1620-8</pub-id>
<pub-id pub-id-type="pmid">28196487</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0018"><mixed-citation publication-type="journal" id="ptr6802-cit-0018">
<string-name>
<surname>Lee</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Boo</surname>, <given-names>K. H.</given-names>
</string-name>, <string-name>
<surname>Woo</surname>, <given-names>J. K.</given-names>
</string-name>, <string-name>
<surname>Duan</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>K. H.</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>, <given-names>T. K.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Lee</surname>, <given-names>D. S.</given-names>
</string-name> (<year>2011</year>). <article-title>Anti&#x02010;bacterial and anti&#x02010;viral activities of extracts from <italic>Terminalia chebula</italic> barks</article-title>. <source xml:lang="en">Journal of Applied Biological Chemistry</source>, <volume>54</volume>, <fpage>295</fpage>&#x02013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.3839/jksabc.2011.046</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0019"><mixed-citation publication-type="journal" id="ptr6802-cit-0019">
<string-name>
<surname>Lee</surname>, <given-names>Y. H.</given-names>
</string-name>, <string-name>
<surname>Jang</surname>, <given-names>Y. H.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>Y. S.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Seong</surname>, <given-names>B. L.</given-names>
</string-name> (<year>2018</year>). <article-title>Evaluation of green tea extract as a safe personal hygiene against viral infections</article-title>. <source xml:lang="en">Journal of Biological Engineering</source>, <volume>12</volume>, <elocation-id>1</elocation-id>
<pub-id pub-id-type="doi">10.1186/s13036-017-0092-1</pub-id>
<pub-id pub-id-type="pmid">29339972</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0020"><mixed-citation publication-type="journal" id="ptr6802-cit-0020">
<string-name>
<surname>Li</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Du</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Hou</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>, <given-names>X.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Cui</surname>, <given-names>Q.</given-names>
</string-name> (<year>2020</year>). <article-title>Identification of Chebulinic acid and Chebulagic acid as novel influenza viral neuraminidase inhibitors</article-title>. <source xml:lang="en">Frontiers in Microbiology</source>, <volume>11</volume>, <fpage>182</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2020.00182</pub-id>
<pub-id pub-id-type="pmid">32256457</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0021"><mixed-citation publication-type="journal" id="ptr6802-cit-0021">
<string-name>
<surname>Liu</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Lin</surname>, <given-names>R.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Han</surname>, <given-names>K.</given-names>
</string-name> (<year>2020</year>). <article-title>Clinical features of COVID&#x02010;19 in elderly patients: A comparison with young and middle&#x02010;aged patients</article-title>. <source xml:lang="en">The Journal of Infection</source>, <volume>80</volume>, <fpage>e14</fpage>&#x02013;<lpage>e18</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.005</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0022"><mixed-citation publication-type="journal" id="ptr6802-cit-0022">
<string-name>
<surname>Mahmood</surname>, <given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>M&#x000e1;rtinez</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Aslam</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Rafique</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Vinet</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Laurido</surname>, <given-names>C.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Ali</surname>, <given-names>S.</given-names>
</string-name> (<year>2016</year>). <article-title>Antiviral effects of green tea (<italic>Camellia sinensis</italic>) against pathogenic viruses in human and animals (a mini&#x02010;review)</article-title>. <source xml:lang="en">African Journal of Traditional, Complementary, and Alternative Medicines</source>, <volume>13</volume>(<issue>2</issue>), <fpage>176</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.4314/ajtcam.v13i2.21</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0023"><mixed-citation publication-type="journal" id="ptr6802-cit-0023">
<string-name>
<surname>Newman</surname>, <given-names>D. J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Cragg</surname>, <given-names>G. M.</given-names>
</string-name> (<year>2007</year>). <article-title>Natural products as sources of new drugs over the last 25&#x02009;years</article-title>. <source xml:lang="en">Journal of Natural Products</source>, <volume>70</volume>, <fpage>461</fpage>&#x02013;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1021/np068054v</pub-id>
<pub-id pub-id-type="pmid">17309302</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0024"><mixed-citation publication-type="journal" id="ptr6802-cit-0024">
<string-name>
<surname>Raghavendhar</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Tripati</surname>, <given-names>P. K.</given-names>
</string-name>, <string-name>
<surname>Ray</surname>, <given-names>P.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Patel</surname>, <given-names>A. K.</given-names>
</string-name> (<year>2019</year>). <article-title>Evaluation of medicinal herbs for anti&#x02010;CHIKV activity</article-title>. <source xml:lang="en">Virology</source>, <volume>533</volume>, <fpage>45</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2019.04.007</pub-id>
<pub-id pub-id-type="pmid">31082733</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0025"><mixed-citation publication-type="journal" id="ptr6802-cit-0025">
<string-name>
<surname>Studier</surname>, <given-names>F. W.</given-names>
</string-name> (<year>2005</year>). <article-title>Protein production by auto&#x02010;induction in high density shaking cultures</article-title>. <source xml:lang="en">Protein Expression and Purification</source>, <volume>41</volume>, <fpage>207</fpage>&#x02013;<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1016/j.pep.2005.01.016</pub-id>
<pub-id pub-id-type="pmid">15915565</pub-id></mixed-citation></ref><ref id="ptr6802-bib-0026"><mixed-citation publication-type="journal" id="ptr6802-cit-0026">
<string-name>
<surname>Varga</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Flammer</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Steiger</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Haberecker</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Andermatt</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Zinkernagel</surname>, <given-names>A. S.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Moch</surname>, <given-names>H.</given-names>
</string-name> (<year>2020</year>). <article-title>Endothelial cell infection and endotheliitis in COVID&#x02010;19</article-title>. <source xml:lang="en">The Lancet</source>, <volume>395</volume>, <fpage>1417</fpage>&#x02013;<lpage>1418</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30937-5</pub-id>
</mixed-citation></ref><ref id="ptr6802-bib-0027"><mixed-citation publication-type="journal" id="ptr6802-cit-0027">
<string-name>
<surname>Xu</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Lu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>D.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Zheng</surname>, <given-names>X.</given-names>
</string-name> (<year>2020</year>). <article-title>Liver injury during highly pathogenic human coronavirus infections</article-title>. <source xml:lang="en">Liver International</source>, <volume>40</volume>, <fpage>998</fpage>&#x02013;<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1111/liv.14435</pub-id>
<pub-id pub-id-type="pmid">32170806</pub-id></mixed-citation></ref></ref-list></back></article>